Monte Rosa Therapeutics Inc. (GLUE) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Monte Rosa Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Monte Rosa Therapeutics Inc. (GLUE) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $909M. It trades at $10.85, up 1.78% today. 8 analysts' average target of $26.86 implies +147.6% from today's price. Kronos AI's 30-day forecast is +36.4% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $26.86 |
| Low – high | $19.00 – $37.00 |
| Analysts | 8 |
| Upside to average | +147.6% |
Kronos AI 30-day forecast
| Expected close | $14.54 (+36.4%) |
| Likely range | +32.3% … +38.8% |
| As of | 2026-10-27 |
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator